HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold 1.8% of their position (20K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.64M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/16/2026ACC: 0001104659-26-062867
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-20K
Net shares
Net seller
$1.64M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−18.66K
Price / share
$82.05
Trade value
$1.53M
% of position
1.6%
5/13/2026
1.14M→1.12M
Common Stock
Direct
Shares
−1.34K
Price / share
$82.58
Trade value
$110.74K
% of position
0.1%
5/13/2026
1.12M→1.12M
Total
Net shares
−20K
Net value
-$1.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | S · Sale | −18.66K | $82.05 | $1.53M | 1.6% | 1.14M | 1.12M |
| Common Stock Direct | 5/13/2026 | S · Sale | −1.34K | $82.58 | $110.74K | 0.1% | 1.12M | 1.12M |
| Total | −20K | -$1.64M | ||||||
Derivative Transactions0
No derivative transactions reported